A native of New Brunswick, Chère Chapman has a Masters in Health Science in Community Health and Epidemiology and global experience in HIV research with injection drug users. After completing her MBA at London Business School, Chère founded Rasbora Consulting to bridge the divide between the private and non-profit sectors. For over a decade, Chère provided guidance to non-profits trying to improve their effectiveness, aided multinationals in developing impactful shared value programs, and facilitated multi-stakeholder partnerships. She has lived and worked in Japan, India, United Kingdom, Vietnam, and Singapore.
In 2015, Chère’s Maritime roots pulled her back to Halifax where she became CEO of DGI Clinical, a contract research organization at the cutting edge of patient-centered health research. In 2021, Chere and her former mentor performed a management buy-out co-found Ardea Outcomes, pivoting from professional services only to an enhanced digital product strategy. Working with the world’s leading pharma, biotech, non-profit, and academic partners in the US and Europe, Chere has taken a purpose-led approach to sustainable growth building a remote-first, values-driven team from Halifax to Vancouver.
Chère is a past board member of the University of King’s College and Touch Sala Bai, a charity fighting human trafficking in Cambodia, a former associate of Creative Destruction Lab, co-founder and inaugural chair of ONSIDE, and co-founder and limited partner of Sandpiper Ventures.